It belongs to a group of compounds known as Growth Hormone Releasing Hormone (GHRH) analogs and is often discussed for its potential role in improving recovery, metabolism, and body composition
Turner DS, Etheridge L, Jones J, Marks V, Meldrum B, Bloom SR, et al
The treatment is administered via a once-weekly subcutaneous injection, typically in the abdomen or thigh
Gonzalez de Vega R, Fernandez-Sanchez ML, Fernandez JC, Alvarez Menendez FV, Sanz-Medel A
Clinical trial data and FDA labeling information indicate that gastrointestinal effects are dose-dependent and typically most pronounced during initial treatment or dose escalation
The real issue is that many patients who need this care never connect with the right